Organic electroluminescent materials and devices

US12552986B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12552986-B2
Application numberUS-202217881372-A
CountryUS
Kind codeB2
Filing dateAug 4, 2022
Priority dateJun 20, 2016
Publication dateFeb 17, 2026
Grant dateFeb 17, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Iridium complexes comprising three different bidentate ligands and their use in OLEDs to enhance the device efficiency and lifetime are disclosed. The complexes have a structure of the formula Ir(L A )(L B )(L C ), where ligand L A is selected from a variety of structures, ligand L B has the structure and L C has the structure In these structures rings A, B, C, and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; R 1 , R 2 , R 3 , R A , R B , R C , and R D can be any of a variety of substituents, and Z 1 and Z 2 are each independently C or N.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A compound having a formula Ir(L A )(L B )(L C ) selected from wherein L A is the ligand with substituents R 1 , R 2 , and R 3 ; wherein L B is the ligand with substituents R A1 , R A2 , and R B ; wherein L C is the ligand with substituents R C and R D ; wherein R 1 , R 2 , R 3 , R A1 , R A2 , R B , R C , and R D each independently represents mono, to a maximum possible number of substitutions, or no substitution; wherein L A , L B , and L C are different from each other, and can be connected to each other to form multidentate ligand; wherein R 1 , R 2 , R 3 , R A1 , R A2 , R B , R C , and R D are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two or more substituents among R 1 , R 2 , R 3 , R A1 , R A2 , R B , R C , and R D are optionally joined or fused into a ring; and wherein at least one of the following is true: (i) at least one R 1 , R 2 , R 3 , R A , R A2 , R B , R C , or R D comprises a moiety selected from the group consisting of heteroalkyl, arylalkyl, alkoxy, aryloxy, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, partially or fully deuterated variants thereof, and partially or fully fluorinated variants thereof; or (ii) an R B is substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, and (a) the R B is joined with an adjacent R B that together with the ring coordinated to the Ir atom forms a dibenzofuran or aza-dibenzofuran moiety, or (b) at least one R A1 , R A2 , or R B is a partially or fully deuterated alkyl or partially or fully fluorinated alkyl. 2 . The compound of claim 1 , wherein at least two of R 1 , R 2 , R 3 , R A1 , R A2 , R B , R C , or R D are independently selected from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, partially or fully deuterated variants thereof, partially or fully fluorinated variants thereof, and combinations thereof. 3 . The compound of claim 1 , wherein at least one of L A , L B , and L C , is selected from the group consisting of: where i in Ai is 1 to 212 and the substituents in L a Ai , L c Ai , and L d Ai are defined as, L a Ai L c Ai , and L d Ai , where i is R 1a R 1b R 2 R 3a R 3b R 3c 1. H H H H H H 2. H CH3 H H H H 3. H CD3 H H H H 4. H C2H5 H H H H 5. H CD2CH3 H H H H 6. H CHMe2 H H H H 7. H CDMe2 H H H H 8. H H H H H 9. H H H H H 10. H H H H H 11. H H H H H 12. H H H H H 13. H

Assignees

Inventors

Classifications

  • of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title

  • with oxygen · CPC title

  • containing one nitrogen atom as the heteroatom · CPC title

  • non-luminescent particle coatings or suspension media · CPC title

  • Iridium compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12552986B2 cover?
Iridium complexes comprising three different bidentate ligands and their use in OLEDs to enhance the device efficiency and lifetime are disclosed. The complexes have a structure of the formula Ir(L A )(L B )(L C ), where ligand L A is selected from a variety of structures, ligand L B has the structure and L C has the structure In these s…
Who is the assignee on this patent?
Universal Display Corp
What technology area does this patent fall under?
Primary CPC classification C07F15/0033. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).